Diamedica TherapeuticsDMAC
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 32 institutions reported holding Diamedica Therapeutics Inc. (DMAC) in their 13F filings, unchanged from Q1 2024. 3 opened new positions and 3 sold out. The largest holders were Omega Advisors (Leon Cooperman) ($4.1M), Vanguard Group Inc. ($3.0M) and First Manhattan Co. Llc. ($2.5M). 2 famous investors held it, including Leon Cooperman (0.2% of Omega Advisors (Leon Cooperman)'s portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Diamedica Therapeutics Inc.
- CUSIP
- 25253X207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $82K |
| Exits | 3 | $72K |
All 13F filers, Q1 2024 → Q2 2024: 716,129 shares bought and 252,115 shares sold, net +464,014 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Omega Advisors (Leon Cooperman) | 0.17% | Add +58.4% | 1,400,000 | $4.1M |
| Vanguard Group Inc. | 0.00% | Add +0.4% | 1,017,402 | $3.0M |
| First Manhattan Co. Llc. | 0.01% | Reduce -1.3% | 839,081 | $2.5M |
| Paragon Associates & Paragon Associates II Joint Venture | 3.48% | Reduce -3.5% | 482,614 | $1.4M |
| Bleichroeder LP | 0.34% | Add +72.0% | 382,317 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Reduce -1.0% | 236,888 | $699K |
| Northern Trust Corp. | 0.00% | Reduce -5.8% | 120,389 | $355K |
| Aristides Capital LLC | 0.13% | No change | 106,333 | $314K |
| BlackRock Inc. | 0.00% | Add +1.9% | 105,303 | $311K |
| Morgan Stanley | 0.00% | Reduce -5.9% | 86,200 | $254K |
| State Street Corp. | 0.00% | Add +3.1% | 68,729 | $203K |
| Susquehanna International Group, LLP | 0.00% | Reduce -79.3% | 43,373 | $128K |
| Catalyst Financial Partners LLC | 0.02% | Add +6.0% | 38,457 | $113K |
| Stonebridge Capital Advisors LLC | 0.01% | No change | 20,000 | $59K |
| LPL Financial LLC | 0.00% | New | 17,500 | $52K |
| Dimensional Fund Advisors LP | 0.00% | No change | 16,959 | $50K |
| BNP Paribas Financial Markets | 0.00% | Add +4.8% | 15,200 | $45K |
| Jane Street Group, LLC | 0.00% | Reduce -1.0% | 15,091 | $45K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 13,251 | $39K |
| Magnolia Capital Advisors LLC | 0.02% | New | 10,000 | $30K |
| Citadel Advisors | 0.00% | Reduce -65.0% | 8,413 | $25K |
| MassMutual Private Wealth & Trust, FSB | 0.00% | No change | 4,824 | $14K |
| US Bancorp \de | 0.00% | No change | 4,335 | $13K |
| Naples Money Management LLC | 0.01% | No change | 2,978 | $9K |
| Osaic Holdings, Inc. | 0.00% | Add +105.5% | 2,055 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -30.0% | 1,888 | $6K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1,070 | $3K |
| Royal Bank of Canada | 0.00% | Add +25.0% | 1,056 | $3K |
| Legend Financial Advisors, Inc. | 0.00% | No change | 1,000 | $3K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 230 | $679 |
| Bank of America Corp. | 0.00% | New | 183 | $540 |
| Toronto Dominion Bank | 0.00% | No change | 24 | $71 |
"% of holder's portfolio" is DMAC's weight in each manager's 13F, not the share of Diamedica Therapeutics Inc. the manager owns.